CytRx Reaches Patient Enrollment Target in Global Phase 2b Clinical Trial with ... PharmaLive (press release) (subscription) CytRx Reaches Patient Enrollment Target in Global Phase 2b Clinical Trial with Tamibarotene as First-Line Treatment for Non-Small-Cell Lung Cancer. Share. Top-Line trial results expected in the second half of ... Patients with stage IIIB or IV squamous ... |
